Trade Halt/Re-Opens @$3.40 / Approved in Europe Anyday Now
Watch for news coming on approval for Illuvien.Alimera still has $38M cash on hand and was already approved by the FDA advisory committee and will be approved by (MHRA) Medicines& Healthcare Regulartory Agency as early as this week.With the cash value at $1.36-$1.50 with assets this is about a no-risk trade under $2.00 now.The Street.Com article on Friday also says go long @ $1.70 which will be soon.The 7M float is getting bought-up now into approval news.